首页> 美国卫生研究院文献>Cancer Science >Regional Expression of CXCL12/CXCR4 in Liver and Hepatocellular Carcinoma and Cell‐cycle Variation during in vitro Differentiation
【2h】

Regional Expression of CXCL12/CXCR4 in Liver and Hepatocellular Carcinoma and Cell‐cycle Variation during in vitro Differentiation

机译:CXCL12 / CXCR4在肝癌和肝细胞癌中的区域表达及体外分化过程中的细胞周期变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The CXCL12/CXCR4 system may be important in carcinoma. Expression of the a‐chemokine SDF‐lα (stromal cell derived factor‐lα)/CXCL12 mRNA is reduced in many carcinomas, yet its tissue protein expression may guide metastasis. Here we first compare the mRNA and protein expression of CXCL12 and its receptor CXCR4 in human liver, hepatocellular carcinoma, and malignant cell lines, and then assess cell cycle variation in CXCR4 expression. CXCR4 mRNA was present in most normal human tissues and malignant cell lines; it was only marginally reduced in hepatomas, while CXCL12 was markedly reduced, P<0.0001. Immuno‐histochemical staining of adjacent non‐malignant liver showed regional CXCR4 cytoplasmic and cell‐surface staining, limited to those hepatocytes around the central vein, a distribution resembling that of CXCL12. CXCL12 protein was not present in hepatocellular carcinoma cells in vivo, nor was cytoplasmic CXCR4 staining; nuclear CXCR4 protein expression in some malignant hepatocytes and CXCR4 staining of capillary endothelial cells around tumor cells were noted. In some malignant cell lines that had no CXCL12 on northern blots CXCL12 was weakly detectable by RT‐PCR or protein staining in the cytoplasm of a few cells. With a view to future manipulation of CXCL12/CXCR4 expression and growth we noted that in HT‐29 cells CXCR4 protein expression was less on confluent than on non‐confluent cells and varied during the cell cycle. Higher expression was associated most closely with the percentage of cells in the S‐phase and inversely with the percentage of cells in the G1‐phase. Treatment of HT‐29 cells with butyrate reduced CXCR4 cell surface expression and reduced the percentage of cells in S‐phase. In summary, CXCL12 protein expression parallels its mRNA, being markedly reduced in malignant cell lines and hepatomas; in liver, the regional distributions of CXCL12 and cytoplasmic CXCR4 are similar; finally, in HT‐29, CXCR4 expression correlates with the S‐phase of the cell cycle and is reduced during butyrate‐induced differentiation.
机译:CXCL12 / CXCR4系统在癌症中可能很重要。在许多癌中,α-趋化因子SDF-1α(基质细胞衍生因子-1α)/ CXCL12 mRNA的表达降低,但其组织蛋白表达可能指导转移。在这里,我们首先比较人肝,肝细胞癌和恶性细胞系中CXCL12及其受体CXCR4的mRNA和蛋白表达,然后评估CXCR4表达中的细胞周期变化。 CXCR4 mRNA存在于大多数正常人组织和恶性细胞系中。在肝癌中仅略有减少,而CXCL12明显减少,P <0.0001。相邻非恶性肝脏的免疫组织化学染色显示区域性CXCR4细胞质和细胞表面染色,仅限于中心静脉周围的肝细胞,其分布类似于CXCL12。体内肝细胞癌细胞中不存在CXCL12蛋白,细胞质CXCR4染色也不存在。观察到一些恶性肝细胞中核CXCR4蛋白的表达以及肿瘤细胞周围毛细血管内皮细胞的CXCR4染色。在一些在Northern印迹上没有CXCL12的恶性细胞系中,通过RT-PCR或少数细胞质中的蛋白染色很难检测到CXCL12。为了将来对CXCL12 / CXCR4表达和生长的操纵,我们注意到在HT-29细胞中,融合细胞的CXCR4蛋白表达比非融合细胞的表达少,并且在细胞周期中有所变化。较高的表达与S期细胞的百分率密切相关,而与G1期细胞的百分率负相关。用丁酸酯处理HT-29细胞会降低CXCR4细胞表面表达,并减少S期细胞的百分比。总之,CXCL12蛋白表达与其mRNA平行,在恶性细胞系和肝癌中显着降低。在肝脏中,CXCL12和细胞质CXCR4的区域分布相似。最后,在HT‐29中,CXCR4表达与细胞周期的S期相关,并在丁酸盐诱导的分化过程中降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号